miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression
Chifumi Ohyagi-Hara(The University of Osaka), Tadashi Kimura(Osaka University), Kae Hashimoto(The University of Osaka), Toshifumi Takahashi(Fukushima Medical University), Ernst Lengyel(University of Illinois Chicago), Shoji Kamiura(Osaka International Cancer Institute), Keiichi Kumasawa(The University of Osaka), Yasuto Kinose(The University of Osaka), Ken-ichirou Morishige, Seiji Mabuchi(The University of Osaka), Yasuhiko Tomita(Osaka International Cancer Institute), Hirohisa Kurachi(Osaka Women's and Children's Hospital), Aki Isobe(The University of Osaka), Shigenori Nagata(Osaka International Cancer Institute), Takeshi Hisamatsu(The University of Osaka), Kenjiro Sawada(Gynecologic Oncology Group)
Cited by 96
Related Papers
Ovarian Cancer Development and Metastasis
|American Journal Of Pathology|2010|1.7k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts
|Nature|2019|510
Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387